L-NAME hydrochloride.|51298-62-5|癌症|Medlife

Medlife小分子 2025-02-13
L-NAME hydrochloride是 NOS 的抑制剂,IC50 为70 μM。

中文名称 :L-NAME hydrochloride.

中文别名:N'-硝基-L-精氨酸甲酯盐酸盐;N-硝基-L-精氨酸甲酯;N(ω)-硝基-L-精氨酸甲酯盐酸盐;N-硝基-L-精氨酸甲酯盐酸盐;NG-硝基-L-精氨酸甲基酯盐酸盐;NG-硝基-L-精氨酸甲酯盐酸盐;Nomega-Nitro-L-arginine Methyl Ester Hydrochloride N(ω)-硝基-L-精氨酸甲酯盐酸盐;Nω-硝基-L-精氨酸甲酯盐酸盐;N-硝基-L-精氨酸甲基酯盐酸盐;N''-硝基-L-精氨酸甲酯盐酸盐;一氧化氮合酶抑制剂;N’-硝基-L-精氨酸甲酯盐酸盐;精氨酸硝基盐酸盐

英文名称:Methyl N5-(imino(nitroamino)methyl)-L-ornithine monohydrochloride

英文别名:(S)-Methyl 2-amino-5-(3-nitroguanidino)pentanoate hydrochloride;H-Arg(NOZ)-OMe.HCl;L-NAME hydrochloride;N'-Nitro-L-arginine methyl ester hydrochloride;Nomega-Nitro-L-arginine Methyl Ester Hydrochloride;L-NAME;(S)-Methyl 2-amino-5-(3-nitroguanidino)-pentanoate hydrochloride;H-Arg(NO?)-OMe·HCl;H-Arg(NO₂)-OMe · HCl;H-Arg(NO2)-OMe.HCl;H-Arg(NO2)-OMe·HCl;H-Arg(NO2)-OMe·HClN-ω-Nitro-L-arginine methyl ester hydrochloride;H-Arg(NO2)-OMe•HCl;L-NAME (hydrochloride);L-NAME,BR;methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate,hydrochloride;NG-Nitroarginine methyl ester hydrochloride;Nitroarginine Methyl;Nitroarginine Methyl Ester Hydrochloride;N'-Nitro-L-arginine-methyl ester hydrochloride;N-ω-Nitro-L-arginine methyl ester hydrochloride;Nω-Nitro-L-arginine methyl ester hydrochloride;NG-Nitro-L-arginine-methyl ester hydrochloride;LNAME hydrochloride;L-NAME HCl;NG-Nitro-L-arginine methyl ester hydrochloride;L-NAME, HCl;L-NAME HCl;NG-NO2-L-Arg-OMe;H-Arg(NO)-OMe HCl;Nomega-NO2-L-Arg-OMe;Methyl N5-(imino(nitroamino)methyl)-L-ornithine monohydrochloride;H-Arg(NO2)-OMeHCl;methyl (2S)-2-amino-5-(3-

Cas No.:51298-62-5

分子式:C7H16ClN5O4

分子量:269.69

包装储存:

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (

生物活性 :L-NAME hydrochloride inhibits NOS with an IC50 of 70 μM. L-NAME is a precursor to NOS inhibitor L-NOARG which has an IC50 value of 1.4 μM.

性状:Solid

IC50 & Target[1][2]

IC50: 70 μM (NOS)

体外研究(In Vitro):

L-arginine analogues are widely used inhibitors of nitric oxide synthase (NOS) activity, with N-nitro-L-arginine methyl ester (L-NAME) being at the head. Freshly dissolved L-NAME is a 50 fold less potent inhibitor of purified brain NOS (mean IC50= 70 μM) than L-NOARG (IC50= 1.4 μM), but the apparent inhibitory potency of L-NAME approached that of L-NOARG upon prolonged incubation at neutral or alkaline pH. HPLC analyses reveal that NOS inhibition by L-NAME closely correlated with hydrolysis of the drug to L-NOARG.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo):

L-NAME infusion significantly decreases NKT-leukocyte level, tumor-necrosis factor (TNF)-alpha production by T-splenocytes and macrophages, and IFNγ production by T-leukocytes, monocytes, and T-splenocytes, as well as increased interleukin-6 production by T-leukocytes and monocytes and nitrate/nitrite production by T-leukocytes. There is increasing evidence that nitric oxide may be involved in learning and memory. l-NAME produces a task-dependent impairment of fear extinction, and implies that nitric oxide signaling is involved in memory process of certain fear extinction tasks. Chronic L-NAME administration induces cardiac hypertrophy in rodent models. Six weeks L-NAME administration induces significant cardiac hypertrophy compared to control hearts.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件:Room temperature or refrigerated transportation.

储存方式:

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial

参考文献:

[1]. Pfeiffer S, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement forbioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol. 1996 Jul;118(6):1433-40. [Information]

[2]. Kopincová J, et al. L-NAME in the cardiovascular system - nitric oxide synthase activator? Pharmacol Rep. 2012;64(3):511-20. [Information]

[3]. Lo HC, et al. The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis. PLoSOne. 2016 Mar 23;11(3):e0151973. [Information]

[4]. Luo H, et al. Effect of nitric oxide synthase inhibitor L-NAME on fear extinction in rats: a task-dependent effect. Neurosci Lett. 2014 Jun 20;572:13-8. [Information]

[5]. Ocsan RJ, et al. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy. J Physiol Pharmacol. 2013 Dec;64(6):727-36. [Information]

sealed storage, away from moisture)


研究方向

  1. 一氧化氮合酶(NOS)抑制研究:

L-NAME hydrochloride作为NOS的抑制剂,被广泛用于研究NOS在生物体内的功能及其与相关疾病的关系。通过抑制NOS的活性,科学家可以观察一氧化氮(NO)生成减少后生物体的生理和病理变化。

  1. 心脑血管疾病模型构建:

L-NAME hydrochloride是一种经典的高血压建模剂。通过给予动物(如大鼠、小鼠)L-NAME hydrochloride,可以减少动物体内NO的释放,从而诱导高血压等心脑血管疾病模型。这些模型对于研究心脑血管疾病的发病机制、药物治疗以及预防策略具有重要意义。

  1. 药物相互作用与药效学研究:

L-NAME hydrochloride还被用于研究与其他药物的相互作用以及药效学特性。例如,在联合用药的情况下,观察L-NAME hydrochloride对其他药物疗效的影响,以及药物代谢和排泄的变化等。

研究目标

  1. 阐明NOS在生物体内的功能:

通过抑制NOS的活性,科学家旨在阐明NOS在生物体内的具体功能,包括其在信号传导、免疫调节、血管舒张等方面的作用。

  1. 探索心脑血管疾病的发病机制:

利用L-NAME hydrochloride诱导的高血压等心脑血管疾病模型,科学家可以深入研究这些疾病的发病机制,为开发新的治疗方法和预防策略提供理论基础。

  1. 优化药物治疗方案:

通过研究L-NAME hydrochloride与其他药物的相互作用以及药效学特性,科学家可以优化药物治疗方案,提高药物治疗的针对性和有效性。

综上所述,L-NAME hydrochloride在科研领域中的研究方向广泛且深入,旨在阐明NOS在生物体内的功能、探索心脑血管疾病的发病机制以及优化药物治疗方案等。这些研究对于推动生物学、药理学以及医学领域的发展具有重要意义。

本文引用地址:https://www.med-life.cn/product/409434.html



版权声明 本文地址:http://www.bioyun.cc/article/qianyan/Medlife1/1564.html
1.产品咨询热线:4006087598;技术支持:www.canspec.cn ;产品赋能:www.perfemiker.cn 小分子专家:www.med-life.cn
2.文章若无特殊说明,均属本站原创,若转载文章请于作者联系。
3.本站除部分作品系原创外,其余均来自网络或其它渠道,本站保留其原作者的著作权!如有侵权,请与站长联系!
抗链霉亲和素抗体